Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global insulin delivery pens market size was exhibited at USD 26,412 million in 2024 and is projected to grow USD 58,086 ...

People with diabetes may use insulin pens, wearable pump devices, or a glass vial and syringe to deliver this needed medication. Costs vary depending on which method you choose. The price of ...

Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...

(MENAFN- GlobeNewsWire - Nasdaq) The global insulin delivery pens market size is predicted to increase from USD 25,578 million in 2025 and is anticipated to reach around USD 58,086 million by 2034 ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

In this study, significantly more patients in the insulin pen group prepared and self-injected at least one dose of insulin compared with the vial and syringe group. Patients with newly diagnosed ...

Diabetologist V Mohan said that people who were using the more expensive pen device could shift to a next-generation insulin that was available from the company; vials or other similar products ...

Small molecules with big potential The two drugs used in this study are already approved to treat rare cancers. Tazemetostat, known under the brand name Tazverik, was approved by the U.S. FDA in ...

Among 35 adults using technosphere insulin in the INHALE-3 trial, 74% increased their daily dose by more than 4 U at 30 weeks. Total daily inhaled insulin dose increased from 36 U at 4 days to 52 ...